Details of the Drug

General Information of Drug (ID: DMOTHNK)

• Drug Name: NB-001
• Synonyms: NanoHPX; Herpes labialis therapy (NanoStat topical formulation), NanoBio; Herpes simplex virus type 1 (HSV-1) therapy (NanoStat topical formulation), NanoBio

Indication

Disease Entry	ICD 11	Status	REF
Multiple sclerosis	8A40	Phase 3	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C12H20N6O
  Canonical SMILES: C1=NC(=C2C(=N1)N(C=N2)CCNCCCCCO)N
  InChI: InChI=1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)
  InChIKey: CVPTTZZCRDVGSU-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 2815031
  ChEBI ID: CHEMBL4297305
  CAS Number: 686301-48-4
  UNII: J89QT81NBQ
  DrugBank ID: DB12716
  TTD ID: D02UOZ
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01695187) NB-001 Treatment of Recurrent Herpes Labialis. U.S. National Institutes of Health.